Listar por tema "Daily practice"
Mostrando ítems 1-1 de 1
-
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients. Castellano, Daniel; González-Larriba, José L.; Antón-Aparicio, Luis M.; Cassinello, Javier; Grande-Pulido, E.; Esteban, Emilio; Sepúlveda, Juan (Expert Opinion on Pharmacotherapy, 2011)